Hanall Biopharma Ltd.

Hanall Biopharma, a South Korean specialty‑drug manufacturer, develops and markets prescription and OTC therapies for gastrointestinal, metabolic, and neurological disorders, plus a pipeline of ophthalmology, immunology, oncology, and neurology products.

Headquarters: South Korea (KOR)

Hanall Biopharma Ltd. Logo
Company Profile
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
009420 Hanall Biopharma Ltd.
Cap: 2613.9B
EQUITY KSC KRW KR7009420001 Active
📈
Home Login